0001654954-21-001750.txt : 20210216
0001654954-21-001750.hdr.sgml : 20210216
20210216193511
ACCESSION NUMBER: 0001654954-21-001750
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210211
FILED AS OF DATE: 20210216
DATE AS OF CHANGE: 20210216
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Brown Michael J
CENTRAL INDEX KEY: 0001035909
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39070
FILM NUMBER: 21641970
MAIL ADDRESS:
STREET 1: C/O EURONET WORLDWIDE, INC.
STREET 2: 11400 TOMAHAWK CREEK PARKWAY, SUITE 300
CITY: LEAWOOD
STATE: KS
ZIP: 66211
FORMER NAME:
FORMER CONFORMED NAME: BROWN MICHAEL J
DATE OF NAME CHANGE: 19970317
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: O'Halloran Thomas V.
CENTRAL INDEX KEY: 0001727481
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39070
FILM NUMBER: 21641971
MAIL ADDRESS:
STREET 1: C/O MONOPAR THERAPEUTICS INC.
STREET 2: 1000 SKOKIE BLVD., SUITE 350
CITY: WILMETTE
STATE: IL
ZIP: 60091
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Robinson Chandler
CENTRAL INDEX KEY: 0001727334
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39070
FILM NUMBER: 21641972
MAIL ADDRESS:
STREET 1: C/O SKOKIE BLVD., SUITE 350
CITY: WILMETTE
STATE: IL
ZIP: 60091
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mazar Andrew Paul
CENTRAL INDEX KEY: 0001727393
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39070
FILM NUMBER: 21641973
MAIL ADDRESS:
STREET 1: 1000 SKOKIE BLVD
STREET 2: SUITE 350
CITY: WILMETTE
STATE: IL
ZIP: 60091
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Tactic Pharma LLC
CENTRAL INDEX KEY: 0001727357
STATE OF INCORPORATION: IL
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39070
FILM NUMBER: 21641974
BUSINESS ADDRESS:
STREET 1: 598 ROCKEFELLER RD.
CITY: LAKE FOREST
STATE: IL
ZIP: 60045
BUSINESS PHONE: 4158279929
MAIL ADDRESS:
STREET 1: C/O SKOKIE BLVD., SUITE 350
CITY: WILMETTE
STATE: IL
ZIP: 60091
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Monopar Therapeutics
CENTRAL INDEX KEY: 0001645469
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 320463781
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1000 SKOKIE BLVD SUITE 350
CITY: WILMETTE
STATE: IL
ZIP: 60091
BUSINESS PHONE: 8473880349
MAIL ADDRESS:
STREET 1: 1000 SKOKIE BLVD SUITE 350
CITY: WILMETTE
STATE: IL
ZIP: 60091
4
1
section16.xml
PRIMARY DOCUMENT
X0306
4
2021-02-11
0001645469
Monopar Therapeutics
MNPR
0001727357
Tactic Pharma LLC
C/O 1000 SKOKIE BLVD, STE 350
WILMETTE
IL
60091
false
false
true
0001727393
Mazar Andrew Paul
C/O 1000 SKOKIE BLVD, STE 350
WILMETTE
IL
60091
true
true
false
Chief Scientific Officer
0001727334
Robinson Chandler
C/O 1000 SKOKIE BLVD, STE 350
WILMETTE
IL
60091
true
true
false
Chief Executive Officer
0001727481
O'Halloran Thomas V.
C/O 1000 SKOKIE BLVD, STE 350
WILMETTE
IL
60091
false
false
true
0001035909
Brown Michael J
C/O 1000 SKOKIE BLVD STE 350
WILMETTE
IL
60091
true
false
false
Common stock
2021-02-11
4
S
false
42467
13.30
D
249200
D
Common stock
2021-02-11
4
S
false
24224
14.09
D
224976
D
Common stock
2021-02-11
4
S
false
29996
15.12
D
194980
D
Common stock
2021-02-11
4
S
false
16384
16.44
D
178596
D
Common stock
2021-02-11
4
S
false
11929
16.90
D
166667
D
Common stock
4111272.88
I
See Footnotes
Trade made pursuant to a 10b5-1 plan executed on November 24, 2020.
This Form 4 is being filed on behalf of Tactic Pharma LLC, an Illinois limited liability company ("Tactic"), and its managers, Andrew P. Mazar, Chandler D. Robinson, Michael J. Brown, and Thomas V. O'Halloran (collectively, the "Reporting Persons"). The managers collectively have voting control over the securities described herein. The managers each disclaim ownership of the shares of common stock owned by Tactic, except to the extent of their pecuniary interest therein.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.66 to $13.65, inclusive. The
reporting person undertakes to provide to Monopar Therapeutics Inc., any security holder of Monopar Therapeutics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3) through (7) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.66 to $14.54, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.76 to $15.75, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.77 to $16.76, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.77 to $17.01, inclusive.
Tactic shares voting and investment power over 4,111,272.88 of the shares of common stock held by TacticGem LLC.
/s/ Kim R. Tsuchimoto, Attorney-in-fact
2021-02-16
/s/ Kim R. Tsuchimoto, Attorney-in-fact
2021-02-16
/s/Kim R. Tsuchimoto, Attorney-in-fact
2021-02-16
/s/Kim R. Tsuchimoto, Attorney-in-fact
2021-02-16
/s/ Kim R. Tsuchimoto, Attorney-in-fact
2021-02-16